| 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 雅下水电概念 | 4.15 | 兵装重组概念 | -4.64 | | 高压氧舱 | 1.55 | 海南自贸区 | -4.19 | | 互联网保险 | 0.56 | 中船系 | -2.76 | | 细胞免疫治疗 | 0.56 | 成飞概念 | -2.50 | | 基因测序 | 0.44 | 特高压 | -2.38 | | CRO概念 | 0.43 | 柔性直流输电 | -2.30 | | 国家大基金持股 | 0.33 | 水泥概念 | -2.21 | | MLOps概念 | 0.33 | 国产航母 | -2.11 | | 智谱AI | 0.33 | 房屋检测 | -1.83 | | DRG/DIP | 0.27 | 军民融合 | -1.80 | 资金面上看，今日高压氧舱概念板块获主力资金净流入0.50亿元，其中，4股获主力资金净流入，净流 入资金居首的是铁建重工，今日主力资金净流入1.03亿元，净流入资金居前的还有国际医学、金陵药 业、澳洋健康等，主力资金分别净流入2472.29万元、39 ...

分析指出，从短期看，医保支付政策的调整，短期内可能对医疗机构的次均费用和住院量产生抑制作 用，但是从长期看，DRG 2.0将促使医疗机构更加重视精细化管理与成本控制，同时推动医疗机构以多 元化服务赢得市场。一方面，DGR支付标准逐步固化临床技术劳务价值，并推动医疗机构聚焦高CMI （病例组合指数）值病种，具备高技术水平的综合医院将显著受益。另一方面，医保支付改革还将推动 综合性医院向非严肃医疗服务和健康管理领域拓展，进一步巩固其市场竞争力。 作为中国西北地区的医疗服务高地，近年来，国际医学主动求变，推行多维度策略，核心聚焦精细化运 营、成本管控、收入结构调整及技术赋能。 2025年是中国DRG（疾病诊断相关分组）支付改革全面深化之年，DRG/DIP（病种分值付费）系统旨 在优化资源配置、控制成本并提高医疗效率。今年年初，DRG/DIP 2.0版分组方案在全国落地，到今年 年底，DRG/DIP支付方式将覆盖所有符合条件的开展住院服务的医疗机构，基本实现病种、医保基金全 覆盖。 作为医保改革的核心，支付方式的改革无疑牵一发而动全身。DRG支付改为预付费制，医院按病种分 组获得固定支付，不再按项目收费，这无疑使得医 ...

Thank you for every brave little buy the dipyou’re the real MVP. 🙌💎 https://t.co/7qkBPUrEk6 ...

Penny Wong’s diplomatic skills will be put to the test in her second term as China continues to bully its neighbours and AUKUS hangs in the balance.The Economist speaks to Australia’s foreign minister https://t.co/Jhv8xVpBKu ...

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.It pays to buy high-yielding stocks at the right price. That’s because buying the dip on a high-yield stock results in far more cash flow than the same dip o ...

TORONTO, July 22, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the investigator-led Phase II trial titled “Prevention Of NephroToxin Induced Acute Kidney Injury with Cilastatin” (PONTIAK) has commenced patient recruitment at its primary clinical sites in Alberta, Canada. The Phase II PONTIAK study aims to evaluate the efficacy of cilastatin in preventing AKI associated with nephrotoxic pharmaceuticals, which include common ...

I was telling you to buy the dip. https://t.co/jHCc1uJw70 ...

10 Americans detained in Venezuela were released in exchange for more than 250 Venezuelans being held in a maximum-security prison in El Salvador, according to U.S. and Salvadoran officials. Photo: U.S. State Department/AFP/Getty Images #WSJ #venezuela #prisonerexchange ...

“I bought the dip” starter pack https://t.co/n6ZRCNDNYw ...

JUST IN: 🇺🇸 Eric Trump celebrates his “₿uy the dips” call. https://t.co/5C73ZjIFPs ...